心臟移植市场按手术方式、适应症、移植物保存、患者年龄层和最终用户划分——2025-2032 年全球预测

预计到 2032 年心臟移植市场规模将成长至 284.5 亿美元，复合年增长率为 10.17%。

主要市场统计数据
基准年2024年	131亿美元
预计2025年	144.1亿美元
预测年份：2032年	284.5亿美元
复合年增长率（%）	10.17%

专注于重塑心臟移植计画和相关人员决策的当代临床、供应链和策略重点

本执行摘要为现代心臟移植领域提供了重点方向，综合了临床进展、供应链动态、监管格局以及影响心臟移植项目和行业战略的营运重点。概述重点介绍了重新定义手术全期护理、器官保存、供体-受体匹配和跨境物流的关键曲折点，同时强调了对医院管理者、移植中心、医疗设备开发商和医疗系统采购方的影响。

本摘要透过对临床方案和产业趋势的综合分析，重点介绍了生态系统面临的最重要趋势和挑战。摘要将临床品质要求与采购现实和技术机会结合。透过强调即时营运回应和中期策略转变，本文件为寻求优化结果、控製成本和加速采用高价值创新的相关人员提供了切实可行的蓝图。其目的是使临床医生、管理人员和供应链领导者能够就优先事项和投资决策进行知情对话，这些优先事项和决策将对未来几年的专案韧性和患者结果产生重大影响。

器官灌注、手术改进和重新设计的护理模式的技术创新如何催化整个心臟移植输送系统的结构变化

心臟移植领域正在经历变革性变革，这得益于技术创新、临床通讯协定的演变以及器官保存和分配方法的转变。器官灌注技术的进步延长了器官的存活期，拓宽了捐赠者标准，从而改变了手术时机、受体选择模式和物流模式。同时，手术技术和手术全期管理的改进正在改善移植物的功能和早期存活率，为各中心重新思考患者治疗路径和容量规划创造了机会。

其他变革力量包括数据驱动的供体-受体匹配的整合、免疫抑制策略的改进，以及对平衡生存和长期生活品质的多学科移植后护理模式的日益重视。这些整合的发展迫使医院和移植中心重新评估其基础设施投资、人员能力以及与设备和保存技术供应商的伙伴关係。随着这种转变的展开，专案负责人越来越多地被要求采用灵活的筹资策略，并在临床、营运和供应链领域开展协作，以在管理复杂性和成本的同时实现临床效益。

评估 2025 年美国关税调整如何改变心臟移植护理的采购经济、供应链弹性和技术采用决策

美国2025年实施的政策变化，尤其是关税调整，为心臟移植供应链带来了层层复杂性，影响了设备、仓储系统和跨境物流。某些医疗设备和零件的关税可能会增加移植专用设备的到岸成本，从而影响医院和移植中心的采购预算。采购成本的上升使专案主管难以权衡，究竟是保留现有供应商，还是投资新兴技术？这些新兴技术可能带来临床效益，但初始购置成本也较高。

关税主导的成本压力也影响储存媒体、一次性组件和灌注平台的全球分销模式。随着供应商寻求替代筹资策略、本地库存和合约保护以降低供应中断的风险，物流调整措施正在兴起。此外，关税也会透过限制某些耗材的供应或限制需要国际製造组件的新设备的快速部署，间接影响临床实践。为了应对这种环境，相关人员正在透过更积极地与供应商就定价进行沟通、投资关键耗材的冗余资源以及重新评估总拥有成本（而不仅仅是领先价格）来维持专案的韧性和临床的连续性。

以细分市场为重点的临床和营运现实，涵盖程序、适应症、保质期、年龄层和最终用户，推动采购和专案实施选择

节段层面的动态变化揭示了不同的临床和手术要点，这些要点必须纳入专案规划和供应商选择。异位植入和原位植入之间的手术差异仍然是外科决策的基础，原位手术又细分为双心房手术和双输卵管手术，这会影响手术全期管理、併发症概况和资源利用率。这些手术分类的差异指南人员配置模式、训练需求和设备适用性评估。

基于适应症的细分突出了不同的患者群体，包括患有先天性心臟疾病、扩大性心肌病、终末期心臟衰竭和缺血性心肌病变的患者，每种疾病对移植前优化要求和移植后护理途径都有独特的影响。这些临床指征也决定了移植的优先顺序和预期的併发症负担，为住院时间预测和长期追踪策略提供资讯。机器灌注和静态低温储存之间的移植物保存选择，以及机器灌注中的低温和常温方法之间的移植物保存选择，会影响运输物流、灌注人员部署和灌注平台投资的决策。患者年龄组（成人、老年和儿童）的差异对移植物选择标准、免疫抑制方案和復健计画有重要影响。最后，医院和移植中心等最终用户的规模、病例组合以及与更广泛的医疗保健系统的整合各不相同，导致采购结构、优先承包方式以及采用新型保存和监测技术的准备程度存在差异。了解这些部分如何相互作用对于协调临床通讯协定与筹资策略以及製定能够在不同项目类型中提供一致结果的实施计划至关重要。

美洲、欧洲、中东和非洲以及亚太地区在临床应用、监管复杂性和供应链策略方面的区域差异将影响实施路径

区域动态正在塑造临床实践模式、法规环境和供应链架构，为不同地区的相关人员制定不同的策略重点。在美洲，成熟的移植网路和整合的数据系统正在支援先进的供体-受体匹配和器官保存技术的快速应用。

在欧洲、中东和非洲，由于法律规范和基础设施成熟度不同，市场呈现两种发展速度：领先的移植中心采用尖端技术，而许多机构则专注于建立基础能力和稳定供应链。这种区域动态影响着伙伴关係模式和分销策略。在亚太地区，不断扩展的临床能力、不断发展的监管途径以及对医疗技术基础设施的积极投资正在加速新型存储和监控解决方案的采用，但广阔地区的物流复杂性和报销差异可能会影响打入市场策略和本地化工作。跨地区、跨境合作、协调的临床通讯协定以及与本地经销商的策略联盟仍然是成功部署技术并扩展专案的关键因素。

竞争态势的特点是技术创新者、现有设备製造商和服务联盟优先考虑临床检验、整合和灵活的商业模式

支持心臟移植治疗的企业环境特点是，专业技术创新者、成熟的医疗设备製造商以及支援物流和保存的服务供应商构成了混合体。专注于机器灌注和器官保存系统的创新者正在透过平台开发、数据化监控以及与运输物流的整合，推动传统冷冻保存模式的转变。同时，领先的器材製造商正在利用其分销规模、监管经验和临床关係，加速市场渗透，并促进新技术的培训计画。

技术开发商、移植物流和物流供应商之间的策略伙伴关係正变得越来越普遍，将临床检验途径与营运解决方案相结合，以管理器官运输和设备运作。强调可靠临床证据、以使用者为中心的设计和生命週期服务支援的公司更有可能被专案负责人接受。随着客户寻求将临床效益与可预测的预算结果相结合，提供灵活商业模式（例如结果驱动合约、託管服务安排和捆绑采购选项）的公司正获得越来越多的关注。竞争差异化越来越依赖展示临床价值、无缝整合到临床工作流程以及对实施后培训和数据分析的支援。

为医院管理人员、移植中心领导和供应商提供可行的策略槓桿，以协调采购、临床实践和伙伴关係，从而维持专案的弹性和成果。

产业领导者和专案主管应采取果断措施，将临床目标与采购和营运策略结合。优先投资于经验证可提高器官存活率和操作灵活性的储存平台，并结合完善的培训计划和跨学科通讯协定，以确保持续使用并实现效益。同时，采用评估总体拥有成本、供应冗余和服务等级协定的采购框架，以保护专案免受供应中断和关税造成的成本波动的影响。

与物流和技术供应商建立策略伙伴关係，共同设计运输和储存工作流程，以减少缺血时间并提高可预测性。投资于数据收集和分析，以衡量临床结果，识别流程瓶颈，并支持循证合约。最后，与政策制定者和付款人合作，沟通先进储存技术的临床和经济价值，并探索报销模式和创新的合约方式，将早期采用的奖励与患者的长期利益相结合。此类合作行动将使您的专案能够在保持财务纪律和营运弹性的同时获得临床效益。

结合临床文献、相关人员访谈、通讯协定分析和操作检验的严格证据综合提供了可操作的项目级见解

本执行摘要所依据的研究整合了同行评审的临床文献、监管指南、手术技术分析以及来自移植临床医生、供应链负责人和技术开发人员的主要定性意见。资料收集包括与多学科相关人员的结构化访谈、临床方案和设备说明书的审查，以及与采购和关税影响相关的政策文件的审查。分析方法将主题定性综合与不同程序和储存方式的操作要求的比较评估相结合。

为了确保研究结果与实务工作者和决策者的相关性，调查方法优先考虑了临床证据、医疗服务提供者能力和实际操作经验的三方检定。研究结果透过与移植外科医生、灌注师和专案经理的反覆咨询检验，以确保与第一线实践保持一致。本研究明确关注系统层面的影响和技术实施考量，而非详细的财务估算，从而能够针对不同的机构背景和准备程度提供切实可行的建议。

整合临床、营运和策略要点，确定哪些移植项目可以从技术创新中受益，同时保持弹性和病患结果。

总而言之，心臟移植领域正处于曲折点，临床创新、保存模式的转变以及供应链动态的演变正在汇聚，重新定义专案策略。灌注技术的进步以及外科和手术全期护理的改进，为扩大捐赠者库和改善疗效创造了机会，而政策变化和采购挑战则要求更复杂的供应链和承包方式。成功的专案将整合临床和手术计划，采用循证技术并提供适当的培训和支持，并建立采购结构以管理成本波动和供应风险。

展望未来，最具韧性的移植计画将把卓越的临床服务与策略采购、数据主导的绩效管理以及贯穿临床和商业生态系统的伙伴关係相结合。透过将投资与检验的临床效益和营运准备相结合，相关人员可以改善患者治疗效果，增强计画的永续性，并加速采用能够显着推进移植治疗的创新技术。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

• 越来越多地使用机器学习演算法来预测捐赠者的心臟适用性和移植后的生存结果
• 引入体外心臟灌注系统以延长供体心臟保存时间并改善移植功能
• 利用基因编辑猪心臟进行异种移植的监管核准和临床整合，以解决捐赠者短缺问题
• 针对 B 细胞耗竭的免疫调节疗法的进展，可降低心臟移植接受者的慢性排斥率
• 整合可穿戴式远端监控设备，用于早期检测移植排斥和个人化患者管理
• 3D生物列印研究对自体心臟组织支架开发以缓解器官短缺的影响
• 供体特异性细胞疗法的出现，增强了移植后的耐受性，并最大限度地减少了终身免疫抑制治疗
• 扩大循环死亡后的器官捐赠通讯协定，以增加捐赠者的可用性并降低等候名单上的死亡率
• 实施人工智慧驱动的决策支援工具，以优化器官分配并改善移植中心的工作流程

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 心臟移植市场（依手术类型）

• 异位移植
• 原位移植
  • 双耳法
  • 双腔静脉入路

第九章心臟移植市场（按适应症）

• 先天性心臟疾病
• 扩大性心肌病
• 末期心臟衰竭
• 缺血性心肌病变

第十章 心臟移植市场（依移植保存）

• 机械灌注
  • 低温灌注
  • 常温灌注
• 静态冷藏保管

第 11 章心臟移植市场（依病患年龄层）

• 成人
• 老年人
• 孩子们

第 12 章 心臟移植市场（依最终用户）

• 医院
• 移植中心

第十三章心臟移植市场（按地区）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章 心臟移植市场（依类别）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十五章 心臟移植市场（依国家）

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章竞争格局

• 2024年市占率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Astellas Pharma Inc.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Sanofi SA
  • Medtronic plc
  • Abbott Laboratories
  • Baxter International Inc.
  • TransMedics, Inc.
  • Paragonix Technologies, Inc.
  • LivaNova PLC

The Heart Transplant Market is projected to grow by USD 28.45 billion at a CAGR of 10.17% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 13.10 billion
Estimated Year [2025]	USD 14.41 billion
Forecast Year [2032]	USD 28.45 billion
CAGR (%)	10.17%

A focused orientation to contemporary clinical, supply chain, and strategic priorities that are reshaping heart transplant programs and stakeholder decision-making

This executive summary offers a focused orientation to the contemporary heart transplant landscape, synthesizing clinical advances, supply chain dynamics, regulatory influences, and operational priorities that shape program-level and industry-level strategy. The overview highlights critical inflection points that are redefining perioperative practice, organ preservation, donor-recipient matching, and cross-border logistics while clarifying the implications for hospital administrators, transplant centers, medical device developers, and health system purchasers.

Through integrated analysis of clinical protocols and industry developments, this summary frames the most consequential trends and tensions facing the ecosystem. It seeks to align clinical quality imperatives with procurement realities and technological opportunities. By emphasizing both immediate operational levers and medium-term strategic shifts, the content provides a pragmatic roadmap for stakeholders aiming to optimize outcomes, control costs, and accelerate adoption of high-value innovations. The intent is to enable informed conversations among clinicians, administrators, and supply chain leaders about priorities and investment decisions that will materially influence program resilience and patient outcomes moving forward.

How technological innovation in organ perfusion, surgical refinement, and care model redesign are catalyzing structural change across heart transplant delivery systems

The heart transplant field is undergoing transformative shifts driven by technological innovation, evolving clinical protocols, and changes in how organs are preserved and allocated. Advances in organ perfusion technologies are extending viable preservation times and broadening donor criteria, which in turn is altering surgical timing, recipient selection frameworks, and logistics models. Concurrently, refinement of surgical techniques and perioperative management is improving graft function and early survival, creating opportunities for centers to reconsider patient pathways and capacity planning.

Other forces of change include the integration of data-driven donor-recipient matching, improvements in immunosuppression strategies, and growing emphasis on multidisciplinary post-transplant care models that balance survival with long-term quality of life. The confluence of these developments is prompting hospitals and transplant centers to reassess infrastructure investments, staff competencies, and partnerships with device and preservation technology suppliers. As these shifts unfold, program leaders are increasingly required to adopt flexible procurement strategies and to collaborate across clinical, operational, and supply chain domains to capture clinical benefits while managing complexity and cost.

Assessing how 2025 tariff adjustments in the United States are altering procurement economics, supply chain resilience, and technology adoption decisions in heart transplant care

Policy changes enacted in 2025 by the United States, specifically tariff adjustments, have introduced a layer of complexity to the heart transplant supply chain that affects devices, preservation systems, and cross-border logistics. Tariffs on certain medical devices and components can increase landed costs for specialized equipment used in transplants, impacting procurement budgets at hospitals and transplant centers. When procurement costs rise, program directors face difficult trade-offs between retaining established suppliers and investing in emergent technologies that promise clinical advantages but may have higher initial acquisition costs.

Tariff-driven cost pressures also influence global distribution patterns for preservation media, single-use components, and perfusion platforms. Logistic adaptations have emerged as providers seek alternative sourcing strategies, localized inventories, and contractual protections to mitigate supply disruption risks. Additionally, tariffs may have indirect clinical implications by constraining the availability of particular consumables or limiting rapid deployment of new devices that require internationally manufactured components. To navigate this environment, stakeholders are engaging more proactively with suppliers on pricing, investing in redundancy for critical supplies, and reassessing total cost of ownership rather than upfront price alone, thereby preserving program resilience and clinical continuity.

Segment-focused clinical and operational realities across procedure, indication, preservation, age group, and end user that determine procurement and program implementation choices

Segment-level dynamics reveal distinct clinical and operational imperatives that must be integrated into program planning and vendor selection. Procedure distinctions between heterotopic and orthotopic transplant remain foundational to surgical decision-making, with orthotopic approaches subdivided into biatrial and bicaval techniques that influence perioperative management, complication profiles, and resource utilization. Such procedural categorical differences guide staffing models, training needs, and device compatibility assessments.

Indication-based segmentation highlights varied patient cohorts such as congenital heart disease, dilated cardiomyopathy, end-stage heart failure, and ischemic cardiomyopathy, each of which carries unique pre-transplant optimization requirements and post-transplant care pathways. These clinical indications also shape allocation priorities and anticipated comorbidity burdens, informing length-of-stay projections and long-term follow-up strategies. Graft preservation choices between machine perfusion and static cold storage, and within machine perfusion between hypothermic and normothermic modalities, affect transport logistics, perfusion staffing, and decisions around investment in perfusion platforms. Patient age group distinctions across adult, geriatric, and pediatric populations have meaningful implications for graft selection criteria, immunosuppression protocols, and rehabilitation planning. Lastly, end users such as hospitals and transplant centers vary in scale, case mix, and integration with broader health systems, which drives differences in purchasing structures, preferred contracting approaches, and readiness to adopt new preservation and monitoring technologies. Understanding how these segments interact is essential for aligning clinical protocols with procurement strategy and for tailoring implementation plans that deliver consistent outcomes across program types.

Regional differentiation in clinical adoption, regulatory complexity, and supply chain strategy across the Americas, Europe Middle East & Africa, and Asia-Pacific that shapes implementation pathways

Regional dynamics shape clinical practice patterns, regulatory environments, and supply chain architectures, creating distinct strategic priorities for stakeholders operating in different geographies. In the Americas, centers benefit from mature transplant networks and integrated data systems that support advanced donor-recipient matching and rapid adoption of preservation innovations, yet they must also contend with differential reimbursement landscapes and state-level regulatory variability that influence capital planning and procurement cycles.

In Europe, the Middle East & Africa, heterogeneity in regulatory frameworks and infrastructure maturity drives a two-speed market where leading transplant centers adopt cutting-edge technologies while many institutions focus on foundational capacity building and supply chain stabilization. This regional mix affects partnership models and distribution strategies. In the Asia-Pacific region, expanding clinical capacity, evolving regulatory pathways, and active investment in medical technology infrastructure are accelerating uptake of novel preservation and monitoring solutions, but logistical complexity across vast geographies and variances in reimbursement can influence market entry strategies and localization efforts. Across all regions, cross-border collaboration, harmonization of clinical protocols, and strategic alliances with local distributors remain decisive factors in successful technology deployment and program scaling.

Competitive dynamics characterized by technology innovators, established device manufacturers, and service alliances that prioritize clinical validation, integration, and flexible commercial models

The corporate landscape supporting heart transplant care is marked by a mix of specialized technology innovators, established medical device manufacturers, and service providers that support logistics and preservation. Innovators focused on machine perfusion and organ preservation systems are driving a shift away from traditional cold storage models through platform development, data-enabled monitoring, and integration with transport logistics. At the same time, larger device manufacturers are leveraging distribution scale, regulatory experience, and clinical relationships to accelerate market penetration and facilitate training programs for new technologies.

Strategic partnerships between technology developers, transplant centers, and logistics providers are becoming more common, combining clinical validation pathways with operational solutions to manage organ transport and device uptime. Companies that emphasize robust clinical evidence, user-centered design, and lifecycle service support tend to achieve greater acceptance among program directors. Additionally, firms that offer flexible commercial models-such as outcome-oriented contracts, managed service arrangements, or bundled procurement options-are gaining traction as customers seek to align clinical benefits with predictable budgetary outcomes. Competitive differentiation increasingly depends on demonstrating clinical value, enabling seamless integration into clinical workflows, and supporting post-deployment training and data analytics.

Actionable strategic measures for hospital executives, transplant center leaders, and vendors to align procurement, clinical practice, and partnerships for sustained program resilience and outcomes

Industry leaders and program directors should take decisive steps to align clinical goals with procurement and operational strategies. Prioritize investments in preservation platforms that have demonstrated improvements in organ viability and operational flexibility, and pair those acquisitions with robust training programs and cross-disciplinary protocols to ensure consistent use and benefit realization. Simultaneously, adopt procurement frameworks that evaluate total cost of ownership, supply redundancy, and service-level agreements to protect programs against supply interruptions and tariff-driven cost volatility.

Cultivate strategic partnerships with logistics and technology providers to co-design transport and preservation workflows that reduce ischemic time and improve predictability. Invest in data capture and analytics to measure clinical outcomes, identify process bottlenecks, and support evidence-based contracting. Finally, engage with policymakers and payers to communicate the clinical and economic value of advanced preservation technologies, seeking reimbursement models or innovative contracting approaches that align incentives for early adoption and long-term patient benefit. These coordinated actions will position programs to capture clinical gains while maintaining fiscal discipline and operational resilience.

A rigorous evidence synthesis combining clinical literature, stakeholder interviews, protocol analysis, and operational validation to produce actionable program-level insights

The research underpinning this executive summary synthesizes peer-reviewed clinical literature, regulatory guidance, operative technique analyses, and primary qualitative inputs from transplant clinicians, supply chain leaders, and technology developers. Data collection included structured interviews with multidisciplinary stakeholders, examination of clinical protocols and device instructions for use, and review of policy documents pertinent to procurement and tariff impacts. Analytical methods combined thematic qualitative synthesis with comparative assessment of operational requirements across procedural and preservation modalities.

To ensure relevance for practitioners and decision-makers, the methodology prioritized triangulation across clinical evidence, supplier capabilities, and real-world operational experience. Insights were validated through iterative consultations with transplant surgeons, perfusionists, and program administrators to align findings with frontline practice. The research explicitly focused on system-level implications and technological adoption considerations rather than on granular financial estimates, enabling practical recommendations suited to diverse institutional contexts and readiness levels.

Synthesis of clinical, operational, and strategic imperatives that will determine which transplant programs capture the benefits of innovation while preserving resilience and patient outcomes

In conclusion, the heart transplant domain is at an inflection point where clinical innovation, shifting preservation paradigms, and evolving supply chain dynamics are converging to redefine program strategy. Advances in perfusion technologies and refinements in surgical and perioperative care are creating opportunities to expand donor pools and improve outcomes, while policy changes and procurement challenges necessitate more sophisticated supply chain and contracting approaches. Successful programs will be those that integrate clinical and operational planning, adopt evidence-backed technologies with appropriate training and support, and structure procurement to manage cost volatility and supply risk.

Looking ahead, the most resilient transplant programs will be those that combine clinical excellence with strategic procurement, data-driven performance management, and collaborative partnerships across the clinical and commercial ecosystem. By aligning investments with validated clinical benefits and operational readiness, stakeholders can improve patient outcomes, enhance program sustainability, and accelerate the adoption of innovations that meaningfully advance transplant care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Growing use of machine learning algorithms to predict donor heart suitability and post-transplant survival outcomes
• 5.2. Adoption of ex vivo heart perfusion systems for extending donor heart preservation time and improving graft function
• 5.3. Regulatory approval and clinical integration of xenotransplantation using gene-edited pig hearts to address donor shortages
• 5.4. Advances in immunomodulatory therapies targeting B-cell depletion to reduce chronic rejection rates in heart transplant recipients
• 5.5. Integration of wearable telemonitoring devices for early detection of graft rejection and personalized patient management
• 5.6. Impact of 3D bioprinting research on development of autologous cardiac tissue scaffolds to mitigate organ scarcity
• 5.7. Emergence of donor-specific cell therapy to enhance tolerance and minimize lifelong immunosuppression regimens post-transplant
• 5.8. Expansion of donation after circulatory death protocols to increase donor availability and reduce waiting list mortality
• 5.9. Implementation of AI-driven decision support tools to optimize organ allocation and improve transplant center workflows

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Transplant Market, by Procedure

• 8.1. Heterotopic Transplant
• 8.2. Orthotopic Transplant
  • 8.2.1. Biatrial Technique
  • 8.2.2. Bicaval Technique

9. Heart Transplant Market, by Indication

• 9.1. Congenital Heart Disease
• 9.2. Dilated Cardiomyopathy
• 9.3. End Stage Heart Failure
• 9.4. Ischemic Cardiomyopathy

10. Heart Transplant Market, by Graft Preservation

• 10.1. Machine Perfusion
  • 10.1.1. Hypothermic Perfusion
  • 10.1.2. Normothermic Perfusion
• 10.2. Static Cold Storage

11. Heart Transplant Market, by Patient Age Group

• 11.1. Adult
• 11.2. Geriatric
• 11.3. Pediatric

12. Heart Transplant Market, by End User

• 12.1. Hospitals
• 12.2. Transplant Centers

13. Heart Transplant Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Heart Transplant Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Heart Transplant Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Astellas Pharma Inc.
  • 16.3.2. Novartis AG
  • 16.3.3. Bristol-Myers Squibb Company
  • 16.3.4. Sanofi S.A.
  • 16.3.5. Medtronic plc
  • 16.3.6. Abbott Laboratories
  • 16.3.7. Baxter International Inc.
  • 16.3.8. TransMedics, Inc.
  • 16.3.9. Paragonix Technologies, Inc.
  • 16.3.10. LivaNova PLC

LIST OF FIGURES

• FIGURE 1. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. AMERICAS HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. EUROPE HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASEAN HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GCC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. BRICS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. G7 HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. NATO HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 30. HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. HEART TRANSPLANT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL HEART TRANSPLANT MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HETEROTOPIC TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIATRIAL TECHNIQUE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BICAVAL TECHNIQUE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CONGENITAL HEART DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL HEART TRANSPLANT MARKET SIZE, BY DILATED CARDIOMYOPATHY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END STAGE HEART FAILURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ISCHEMIC CARDIOMYOPATHY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HYPOTHERMIC PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL HEART TRANSPLANT MARKET SIZE, BY NORMOTHERMIC PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL HEART TRANSPLANT MARKET SIZE, BY STATIC COLD STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL HEART TRANSPLANT MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. AMERICAS HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 124. AMERICAS HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 125. AMERICAS HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 126. AMERICAS HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 127. AMERICAS HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 128. AMERICAS HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 129. AMERICAS HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 130. AMERICAS HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 131. AMERICAS HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 132. AMERICAS HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 133. AMERICAS HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 134. AMERICAS HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 135. AMERICAS HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 136. AMERICAS HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 137. AMERICAS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 138. AMERICAS HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 139. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 142. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 143. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 144. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 145. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 146. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 147. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 148. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 149. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 150. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 151. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 152. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 153. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 154. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 155. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 156. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 157. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 158. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 159. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 160. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 161. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 162. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 163. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 164. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 165. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 166. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 167. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 168. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 169. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 170. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 183. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 184. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 185. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 186. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 187. EUROPE HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 188. EUROPE HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 189. EUROPE HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 190. EUROPE HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 191. EUROPE HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 192. EUROPE HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 193. EUROPE HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 194. EUROPE HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 195. EUROPE HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 196. EUROPE HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 197. EUROPE HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 198. EUROPE HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 199. EUROPE HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 200. EUROPE HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 201. EUROPE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 202. EUROPE HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 203. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 204. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 205. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 206. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 207. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 208. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 209. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 210. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 211. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 212. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 213. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 214. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 215. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 216. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 217. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 218. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 219. AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 220. AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 221. AFRICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 222. AFRICA HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 223. AFRICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 224. AFRICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 225. AFRICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 226. AFRICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 227. AFRICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 228. AFRICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 229. AFRICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 230. AFRICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 231. AFRICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 232. AFRICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 233. AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 234. AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 235. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 236. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 237. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 238. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 239. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 240. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 241. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 242. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 243. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 244. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 245. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 246. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 247. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 248. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 249. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 250. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 251. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 252. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 253. ASEAN HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 254. ASEAN HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 255. ASEAN HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 256. ASEAN HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 257. ASEAN HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 258. ASEAN HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 259. ASEAN HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 260. ASEAN HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 261. ASEAN HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 262. ASEAN HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 263. ASEAN HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 264. ASEAN HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 265. ASEAN HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 266. ASEAN HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 267. ASEAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 268. ASEAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 269. GCC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 270. GCC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 271. GCC HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 272. GCC HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 273. GCC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 274. GCC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 275. GCC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 276. GCC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 277. GCC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 278. GCC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 279. GCC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 280. GCC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 281. GCC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 282. GCC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 283. GCC HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 284. GCC HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 285. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 286. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 287. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 288. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 289. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 290. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 291. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 292. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 293. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 294. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 295. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 296. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 297. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 298. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 299. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 300. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 301. BRICS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 302. BRICS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 303. BRICS HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 304. BRICS HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 305. BRICS HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 306. BRICS HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 307. BRICS HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 308. BRICS HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 309. BRICS HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 310. BRICS HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 311. BRICS HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 312. BRICS HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 313. BRICS HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 314. BRICS HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 315. BRICS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 316. BRICS HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 317. G7 HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 318. G7 HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 319. G7 HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 320. G7 HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 321. G7 HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 322. G7 HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 323. G7 HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 324. G7 HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
• TABLE 325. G7 HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2024 (USD MILLION)
• TABLE 326. G7 HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025-2032 (USD MILLION)
• TABLE 327. G7 HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2024 (USD MILLION)
• TABLE 328. G7 HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2025-2032 (USD MILLION)
• TABLE 329. G7 HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 330. G7 HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 331. G7 HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 332. G7 HEART TRANSPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 333. NATO HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 334. NATO HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 335. NATO HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
• TABLE 336. NATO HEART TRANSPLANT MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
• TABLE 337. NATO HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2024 (USD MILLION)
• TABLE 338. NATO HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2025-2032 (USD MILLION)
• TABLE 339. NATO HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
• TABLE 340. NATO HEART TRANSPLANT MARKET SIZE, BY IND